Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Micrornas in Rheumatoid Arthritis Publisher Pubmed



Salehi E1 ; Eftekhari R1 ; Oraei M2 ; Gharib A3 ; Bidad K4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Immunology Department, School of Medicine, Tehran University of Medical Sciences, Poursina St, Ghods St, Enghelab Ave, Tehran, 1417613151, Iran
  2. 2. Immunology Department, School of Public Health, Tehran University of Medical Sciences, Poursina St, Ghods St, Enghelab Ave, Tehran, 1417613151, Iran
  3. 3. Naamdar Medical Diagnostic Lab, Tehran University of Medical Sciences, No. 118, Fathi Shaghaghi St, Yousef Abad Ave, Tehran, Iran
  4. 4. Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, No. 62, Gharib St, Keshavarz Blvd, Tehran, 14194, Iran

Source: Clinical Rheumatology Published:2015


Abstract

The role of genetic and epigenetic factors in the development of rheumatic diseases has been an interesting field of research over the past decades all around the world. Research on the role of microRNAs (miRNAs) in rheumatoid arthritis (RA) has been active and ongoing, and investigations have attempted to use miRNAs as biomarkers in disease diagnosis, prognosis, and treatment. This review focuses on experimental researches in the field of miRNAs and RA to present the data available up to this date and includes researches searched by keywords “microRNA” and “rheumatoid arthritis” in PubMed from 2008 to January 2015. All references were also searched for related papers. miRNAs are shown to act as proinflammatory or anti-inflammatory agents in diverse cell types, and their role seems to be regulatory in most instances. Researchers have evaluated miRNAs in patients compared to controls or have investigated their role by overexpressing or silencing them. Multiple targets have been identified in vivo, in vitro, or in silico, and the researches still continue to show their efficacy in clinical settings. © 2015, International League of Associations for Rheumatology (ILAR).
Related Docs
View other Related Docs
1. Implications of the Noncoding Rnas in Rheumatoid Arthritis Pathogenesis, Journal of Cellular Physiology (2018)
2. Epigenetics in Rheumatoid Arthritis; Fibroblast-Like Synoviocytes As an Emerging Paradigm in The Pathogenesis of the Disease, Immunology and Cell Biology (2020)
3. Micrornas-Mediated Regulation Pathways in Rheumatic Diseases, Inflammopharmacology (2023)
4. Plasma Levels of Microrna-146A-5P, Microrna-24-3P, and Microrna-125A-5P As Potential Diagnostic Biomarkers for Rheumatoid Arthritis, Iranian Journal of Allergy# Asthma and Immunology (2021)
5. A Comprehensive Review on Mir-146A Molecular Mechanisms in a Wide Spectrum of Immune and Non-Immune Inflammatory Diseases, Immunology Letters (2020)
6. A Systems Biology Approach for Mirna-Mrna Expression Patterns Analysis in Rheumatoid Arthritis, Combinatorial Chemistry and High Throughput Screening (2021)
7. Comparison of Plasma Levels of Microrna-155-5P, Microrna-210-3P, and Microrna-16-5P in Rheumatoid Arthritis Patients With Healthy Controls in a Case-Control Study, Iranian Journal of Allergy# Asthma and Immunology (2023)
8. Epigenetic Modifications and Epigenetic Based Medication Implementations of Autoimmune Diseases, Biomedicine and Pharmacotherapy (2017)
Experts (# of related papers)
View all Related Experts
Mahdi Mahmoudi (7)
Ahmad Reza Jamshidi (6)
Other Related Docs
9. The Role of Β-D-Mannuronic Acid, As a New Non-Steroidal Anti-Inflammatory Drug on Expression of Mir-146A, Irak1, Traf6, Nf-Κb and Pro-Inflammatory Cytokines Following a Clinical Trial in Rheumatoid Arthritis Patients, Immunopharmacology and Immunotoxicology (2020)
10. Immunopharmacological Effect of Β-D-Mannuronic Acid (M2000), As a New Immunosuppressive Drug, on Gene Expression of Mir-155 and Its Target Molecules (Socs1, Ship1) in a Clinical Trial on Rheumatoid Arthritis Patients, Drug Development Research (2020)
11. Microrna Signature of Regulatory T Cells in Health and Autoimmunity, Biomedicine and Pharmacotherapy (2018)
12. Epigenetic Alterations Underlying Autoimmune Diseases, Autoimmunity (2016)
13. Epigenetics of Autoimmune Diseases, Prognostic Epigenetics (2019)
14. Inhibitory Effect of G2013 Molecule As a Novel Immunomodulatory Agent, on Mir-155 Gene Expression in Hek-Blue Htlr4 Cell Line, European Journal of Inflammation (2016)
15. Immunologic Balance of Regulatory T Cell/T Helper 17 Responses in Gastrointestinal Infectious Diseases: Role of Mirnas, Microbial Pathogenesis (2019)
16. Mirna-146A Improves Immunomodulatory Effects of Msc-Derived Exosomes in Rheumatoid Arthritis, Current Gene Therapy (2020)
17. Anti-Inflammatory Micrornas and Their Potential for Inflammatory Diseases Treatment, Frontiers in Immunology (2018)
18. The P53 Status in Rheumatoid Arthritis With Focus on Fibroblast-Like Synoviocytes, Immunologic Research (2021)
19. Transformation of Fibroblast‐Like Synoviocytes in Rheumatoid Arthritis; From a Friend to Foe, Autoimmunity Highlights (2021)
20. Exosome Application in Treatment and Diagnosis of B-Cell Disorders: Leukemias, Multiple Sclerosis, and Arthritis Rheumatoid, Cellular and Molecular Biology Letters (2022)
21. Role of Exosome in Autoimmunity, With a Particular Emphasis on Rheumatoid Arthritis, International Journal of Rheumatic Diseases (2021)
22. Microrna Involvement in the Regulation of Survivin in Peripheral Blood Mononuclear Cells From Rheumatoid Arthritis Patients, International Journal of Rheumatic Diseases (2019)
23. Pharmacological Effects of Β-D-Mannuronic Acid (M2000) on Mir-146A, Irak1, Traf6 and Nf-Κb Gene Expression, As Target Molecules in Inflammatory Reactions, Pharmacological Reports (2017)
24. Expression of Microrna-155 in Patients With Non-Hodgkin Lymphoma, Coronavirus Disease 2019, or Both: A Cross-Sectional Study, Iranian Journal of Medical Sciences (2023)
25. Altered Microrna Expression and Immunosuppressive Cytokine Production by Regulatory T Cells of Ulcerative Colitis Patients, Immunological Investigations (2016)
26. Non-Coding Rna-Mediated Epigenetic Alterations in Grave's Ophthalmopathy: A Scoping Systematic Review, Non-coding RNA Research (2023)
27. Novel Targeted Therapies for Rheumatoid Arthritis Based on Intracellular Signalling and Immunometabolic Changes: A Narrative Review, Frontiers in Bioscience - Landmark (2024)
28. Expression of Circulatory Microrna-155 in Non-Hodgkin Lymphomas and Rheumatoid Arthritis, Medical Journal of Tabriz University of Medical Sciences (2022)
29. Downregulated Microrna-155 Expression in Peripheral Blood Mononuclear Cells of Type 2 Diabetic Patients Is Not Correlated With Increased Inflammatory Cytokine Production, Cytokine (2015)